Nancy Miller-Rich Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Nancy Miller-Rich.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Nancy Miller-Rich. Nancy Miller-Rich is a Director in INTERCEPT PHARMACEUTICALS, INC. ($ICPT) and a Director in Aldeyra Therapeutics, Inc. ($ALDX) and a in Kadmon Holdings, Inc. ($KDMN) and a Director in 4D Molecular Therapeutics Inc. ($FDMT).
Address: C/O INTERCEPT PHARMACEUTICALS, INC. 10 HUDSON YARDS, 37TH FL NEW YORK 10001 NY
Companies in which Nancy Miller-Rich is an Insider
4D Molecular Therapeutics Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Nancy Miller-Rich: Director
Holdings: 0 shares
Latest Transaction: May 19 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Aldeyra Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Nancy Miller-Rich: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 11 2020
$ALDX Market Capitalization: $30.29M
$ALDX Previous Close: $5.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INTERCEPT PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Nancy Miller-Rich: Director
Holdings: 7,538 shares
Current Value: $856,091
Latest Transaction: Jun 01 2020
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kadmon Holdings, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Nancy Miller-Rich:
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 13 2021
$KDMN Market Capitalization: $176.71M
$KDMN Previous Close: $3.99
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Nancy Miller-Rich
Sentiment: All, FDMT, ALDX, ICPT, KDMN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 19 2021 | FDMT | 4D Molecular Thera ... | Miller-Rich Nancy | Director | Option Exercise | A | 26.89 | 22,500 | 605,025 | 22,500 | |
| May 19 2021 | FDMT | 4D Molecular Thera ... | Miller-Rich Nancy | Director | Option Exercise | A | 26.89 | 22,500 | 605,025 | 22,500 | |
| May 13 2021 | KDMN | Kadmon Holdings, I ... | Miller-Rich Nancy | Option Exercise | A | 3.58 | 96,975 | 347,171 | 96,975 | ||
| Aug 13 2020 | KDMN | Kadmon Holdings, I ... | Miller-Rich Nancy | Option Exercise | A | 4.17 | 36,364 | 151,638 | 36,364 | ||
| Jun 11 2020 | ALDX | Aldeyra Therapeuti ... | Miller-Rich Nancy | Director | Option Exercise | A | 5.02 | 26,503 | 133,045 | 26,503 | |
| Jun 01 2020 | ICPT | INTERCEPT PHARMACE ... | Miller-Rich Nancy | Director | Option Exercise | A | 72.74 | 2,966 | 215,747 | 2,966 | |
| Jun 01 2020 | ICPT | INTERCEPT PHARMACE ... | Miller-Rich Nancy | Director | Grant | A | 0.00 | 1,595 | 0 | 7,538 | 5.9 K to 7.5 K (+26.84 %) |